Can-Fite BioPharma Ltd. financial statements
Can-Fite BioPharma Ltd.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.
FY2025
| Revenue | USD 405K | 20-F |
| Net income | −USD 9.83M | 20-F |
| Cash and equivalents | USD 5.53M | 20-F |
| Total debt | USD 71.01K | EODHD |
Can-Fite BioPharma Ltd. financials on 6ix · Can-Fite BioPharma Ltd. on 6ix